Biosergen AB (BIOSGN.ST)

SEK 0.51

(-5.9%)

Eps Summary of Biosergen AB

  • Biosergen AB's latest annual eps in 2023 was -0.60 SEK , up 6.25% from previous year.
  • Biosergen AB's latest quarterly eps in 2024 Q2 was -0.04 SEK , up 71.43% from previous quarter.
  • Biosergen AB reported an annual eps of -0.64 SEK in 2022, up 1.54% from previous year.
  • Biosergen AB reported an annual eps of -0.65 SEK in 2021, down -1767.82% from previous year.
  • Biosergen AB reported a quarterly eps of -0.04 SEK for 2024 Q2, up 71.43% from previous quarter.
  • Biosergen AB reported a quarterly eps of -0.11 SEK for 2023 Q2, down -57.14% from previous quarter.

Annual Eps Chart of Biosergen AB (2023 - 2019)

Historical Annual Eps of Biosergen AB (2023 - 2019)

Year Eps Eps Growth
2023 -0.60 SEK 6.25%
2022 -0.64 SEK 1.54%
2021 -0.65 SEK -1767.82%
2020 -0.03 SEK -32.82%
2019 -0.03 SEK 0.0%

Peer Eps Comparison of Biosergen AB

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -9.091%
Ziccum AB (publ) -1.54 SEK 61.039%
Modus Therapeutics Holding AB (publ) -1.01 SEK 40.594%
BioArctic AB (publ) 2.60 SEK 123.077%
Sprint Bioscience AB (publ) -0.01 SEK -9423.81%
Mendus AB (publ) -4.40 SEK 86.364%
Genovis AB (publ.) 0.94 SEK 163.83%
Intervacc AB (publ) -1.69 SEK 64.497%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -172.727%
Active Biotech AB (publ) -0.17 SEK -252.941%
Magle Chemoswed Holding AB (publ) 1.13 SEK 153.097%
Bio-Works Technologies AB (publ) -1.57 SEK 61.783%
Aptahem AB (publ) -0.05 SEK -1142.236%
Vicore Pharma Holding AB (publ) -3.22 SEK 81.366%
Kancera AB (publ) -0.80 SEK 25.0%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 93.97%
Fluicell AB (publ) -0.24 SEK -150.0%
Saniona AB (publ) -1.29 SEK 53.488%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -215.789%
Biovica International AB (publ) -2.14 SEK 71.963%
Spago Nanomedical AB (publ) -0.43 SEK -39.535%
AcouSort AB (publ) -1.29 SEK 53.488%
Xintela AB (publ) -0.13 SEK -361.538%
Abliva AB (publ) -0.09 SEK -563.717%
Egetis Therapeutics AB (publ) -1.27 SEK 52.756%
Karolinska Development AB (publ) 0.02 SEK 3100.0%
OncoZenge AB (publ) -1.36 SEK 55.882%
Amniotics AB (publ) -0.01 SEK -5354.545%
2cureX AB (publ) -1.85 SEK 67.568%
CombiGene AB (publ) -1.80 SEK 66.667%
Asarina Pharma AB (publ) -0.57 SEK -5.263%
Calliditas Therapeutics AB (publ) -8.69 SEK 93.096%
Camurus AB (publ) 7.78 SEK 107.712%
Corline Biomedical AB -0.08 SEK -612.589%
IRLAB Therapeutics AB (publ) -3.43 SEK 82.507%
Isofol Medical AB (publ) -0.23 SEK -160.87%
I-Tech AB 1.70 SEK 135.294%
Hansa Biopharma AB (publ) -15.83 SEK 96.21%
Cyxone AB (publ) -0.22 SEK -172.727%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 69.697%
Cantargia AB (publ) -1.65 SEK 63.636%
NextCell Pharma AB -1.03 SEK 41.748%
Xspray Pharma AB (publ) -6.76 SEK 91.124%
Elicera Therapeutics AB (publ) -0.83 SEK 27.711%
Nanologica AB (publ) -2.05 SEK 70.732%
SynAct Pharma AB -6.64 SEK 90.964%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -130.769%
Stayble Therapeutics AB (publ) -0.92 SEK 34.783%
LIDDS AB (publ) -0.63 SEK 4.762%
Lipum AB (publ) -4.45 SEK 86.517%
BioInvent International AB (publ) -5.02 SEK 88.048%
Alzinova AB (publ) -0.41 SEK -46.341%
Oncopeptides AB (publ) -1.96 SEK 69.388%
Pila Pharma AB (publ) -0.47 SEK -27.66%
Guard Therapeutics International AB (publ) -11.26 SEK 94.671%
Scandinavian ChemoTech AB (publ) -1.13 SEK 46.903%
Simris Alg AB (publ) -0.16 SEK -275.0%
Diamyd Medical AB (publ) -1.60 SEK 62.5%
Xbrane Biopharma AB (publ) -1.27 SEK 52.756%
Ascelia Pharma AB (publ) -3.24 SEK 81.481%
Diagonal Bio AB (publ) -0.32 SEK -87.5%